Travere Therapeutics【TVTX】株式ニュース

名称	銘柄コード	市場	種別
Travere Therapeutics Inc	TVTX	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.10	-1.47%	6.70	23:48:28

始値	安値	高値	終値	前日終値
6.80	6.63	7.09		6.80

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/16	06:00	GLOBE	Travere Therapeutics Reports Inducement Grants Under Nasdaq..
2024/5/14	05:05	EDGAR2	Form 8-K - Current report
2024/5/11	05:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/11	05:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/11	05:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/11	05:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/11	05:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/11	05:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/10	05:30	GLOBE	Travere Therapeutics to Present at National Kidney..
2024/5/09	05:30	GLOBE	Travere Therapeutics to Present at Upcoming Investor..
2024/5/07	05:46	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/07	05:05	EDGAR2	Form 8-K - Current report
2024/5/07	05:01	GLOBE	Travere Therapeutics Reports First Quarter 2024 Financial..
2024/4/30	05:30	GLOBE	Travere Therapeutics to Report First Quarter 2024 Financial..
2024/4/24	20:05	GLOBE	Travere Therapeutics and CSL Vifor Announce European..
2024/4/24	16:00	PRNCA	CSL Vifor and Travere Therapeutics Announce European..
2024/4/05	05:30	GLOBE	Travere Therapeutics to Present Abstracts at the Society for..
2024/4/04	05:30	GLOBE	Travere Therapeutics to Present Abstracts on FILSPARI®..
2024/3/14	06:00	GLOBE	Travere Therapeutics Reports Inducement Grants Under Nasdaq..
2024/3/11	20:05	GLOBE	Travere Therapeutics Submits Supplemental New Drug..
2024/2/27	06:30	GLOBE	Travere Therapeutics to Present at Upcoming Investor..
2024/2/24	06:05	EDGAR2	Form 8-K - Current report
2024/2/23	21:05	GLOBE	Travere Therapeutics and CSL Vifor Announce Sparsentan..
2024/2/23	16:00	PRNCA	CSL Vifor and Travere Therapeutics announce sparsentan..
2024/2/20	22:10	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/16	06:05	EDGAR2	Form 8-K - Current report
2024/2/16	06:01	GLOBE	Travere Therapeutics Reports Fourth Quarter and Full Year..
2024/2/15	04:35	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/09	06:30	GLOBE	Travere Therapeutics to Report Fourth Quarter and Full Year..
2024/2/03	06:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/03	06:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/03	06:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/03	06:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/03	06:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/03	06:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/02	11:58	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/02	11:58	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/02	11:57	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/02	06:30	GLOBE	Travere Therapeutics to Present at the Guggenheim 6th Annual..
2024/2/02	02:44	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/01	23:52	EDGAR2	Form 144 - Report of proposed sale of securities
2024/1/26	06:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/26	06:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/26	06:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/26	06:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/26	06:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/26	06:05	GLOBE	Travere Therapeutics Announces Licensing Agreement with..
2024/1/24	03:17	EDGAR2	Form 144 - Report of proposed sale of securities
2024/1/24	00:51	EDGAR2	Form 144 - Report of proposed sale of securities
2024/1/08	21:07	EDGAR2	Form 8-K - Current report